# ![@BiotechAnalysst Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::967435696188293125.png) @BiotechAnalysst Phoenix Biotech

Phoenix Biotech posts on X about $sgmo, $qure, $4503t, data the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/twitter::967435696188293125/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::967435696188293125/c:line/m:interactions.svg)

- [--] Week [------] -4.10%
- [--] Month [-------] +13%
- [--] Months [---------] -44%
- [--] Year [---------] +147%

### Mentions: [--] [#](/creator/twitter::967435696188293125/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::967435696188293125/c:line/m:posts_active.svg)

- [--] Week [--] +8.10%
- [--] Month [---] -88%
- [--] Months [-----] +330%
- [--] Year [-----] +138%

### Followers: [-----] [#](/creator/twitter::967435696188293125/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::967435696188293125/c:line/m:followers.svg)

- [--] Week [-----] +0.10%
- [--] Month [-----] +1.90%
- [--] Months [-----] +17%
- [--] Year [-----] +29%

### CreatorRank: [-------] [#](/creator/twitter::967435696188293125/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::967435696188293125/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  28.83% [finance](/list/finance)  10.43% [cryptocurrencies](/list/cryptocurrencies)  5.52% [financial services](/list/financial-services)  3.68% [countries](/list/countries)  1.84% [travel destinations](/list/travel-destinations)  1.23% [technology brands](/list/technology-brands)  0.61% [exchanges](/list/exchanges)  0.61%

**Social topic influence**
[$sgmo](/topic/$sgmo) #2, [$qure](/topic/$qure) #8, [$4503t](/topic/$4503t) #11, [data](/topic/data) 9.2%, [$pfe](/topic/$pfe) 9.2%, [$pgen](/topic/$pgen) #2, [$xbi](/topic/$xbi) 6.13%, [update](/topic/update) 5.52%, [ceo](/topic/ceo) #4213, [target](/topic/target) 4.29%

**Top accounts mentioned or mentioned by**
[@thenewceo_](/creator/undefined) [@desertdweller93](/creator/undefined) [@dudebiotech](/creator/undefined) [@jota5571189851](/creator/undefined) [@jasonmmast](/creator/undefined) [@corona_n_lyme](/creator/undefined) [@zinselmeyerb](/creator/undefined) [@anssiapina](/creator/undefined) [@meangenebio](/creator/undefined) [@quakerbrothers](/creator/undefined) [@sangamotx](/creator/undefined) [@sp28947316](/creator/undefined) [@financebully](/creator/undefined) [@auditor112017](/creator/undefined) [@joshinvestvalue](/creator/undefined) [@eikontx](/creator/undefined) [@floszcrxl](/creator/undefined) [@doepkemichel](/creator/undefined) [@profdollar](/creator/undefined) [@rnaianalyst](/creator/undefined)

**Top assets mentioned**
[uniQure N.V. (QURE)](/topic/$qure) [Pfizer, Inc. (PFE)](/topic/$pfe) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Vertex Protocol (VRTX)](/topic/$vrtx) [Synthetify (SNY)](/topic/$sny) [Goldman Sachs (GS)](/topic/goldman-sachs) [Biogen Inc (BIIB)](/topic/$biib) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Eli Lilly and Company (LLY)](/topic/$lly) [Disc Medicine, Inc. Common Stock (IRON)](/topic/$iron) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [BEAM (BEAM)](/topic/$beam) [Prime Medicine, Inc. (PRME)](/topic/$prme) [Taysha Gene Therapies, Inc. (TSHA)](/topic/$tsha) [Kiniksa Pharmaceuticals, Ltd. Class A Common Stock (KNSA)](/topic/$knsa) [Insmed, Inc. (INSM)](/topic/$insm) [Catalyst Pharmaceutical  Inc. (CPRX)](/topic/$cprx) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Terns Pharmaceuticals, Inc. (TERN)](/topic/$tern) [ArbitrageCT (ARCT)](/topic/$arct) [Amicus Therapeutics, Inc (FOLD)](/topic/$fold) [Sanofi (SNY)](/topic/sanofi) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Krystal Biotech, Inc. Common Stock (KRYS)](/topic/$krys) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) [ADMA Biologics, Inc. (ADMA)](/topic/$adma) [Revolution Medicines, Inc. (RVMD)](/topic/$rvmd) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [SuperRare (RARE)](/topic/$rare) [Metagenomi Technologies, LLC (MGX)](/topic/$mgx) [Carlisle Companies, Inc. (CSL)](/topic/$csl) [Monte Rosa Therapeutics, Inc. (GLUE)](/topic/$glue) [Annexon, Inc. (ANNX)](/topic/$annx) [Alignment Healthcare, Inc. (ALHC)](/topic/$alhc) [Tyra Biosciences, Inc. (TYRA)](/topic/$tyra) [Universal Health Services, Inc. Class B (UHS)](/topic/$uhs)
### Top Social Posts
Top posts by engagements in the last [--] hours

"$PGEN $SGMO lot of similarities between the two company's journeys"  
[X Link](https://x.com/BiotechAnalysst/status/2021862490846457926)  2026-02-12T08:22Z [----] followers, [----] engagements


"BREAKING $SGMO Nav1.7 gene tx for SFN Pain dose escalation is underway (4 sites activated) @ earnings will provide add'l clarity into timing for #initial 12wk #data said will incl 1st two cohorts (n=3 each; randomized 2:1 vs sham) and pot'ly some pts from 3rd high-dose cohort @JoshInvestValue NAV1.7 pain trial: $SGMO says dosing to start in october $SGMO CEO says expects NAV1.7 first PAIN #results as early as [--] #weeks after dosing but could be as early as 4-6 #weeks @JoshInvestValue NAV1.7 pain trial: $SGMO says dosing to start in october $SGMO CEO says expects NAV1.7 first PAIN #results as"  
[X Link](https://x.com/BiotechAnalysst/status/2021958860354007226)  2026-02-12T14:45Z [----] followers, 10.8K engagements


"Statestreet adding 6.3M $PGEN shares SymBiosis Capital Management LLC (biotechnology-focused investment firm) starts new $PGEN position with 3M shares https://t.co/r0LBE16Kdq SymBiosis Capital Management LLC (biotechnology-focused investment firm) starts new $PGEN position with 3M shares https://t.co/r0LBE16Kdq"  
[X Link](https://x.com/BiotechAnalysst/status/2022338819329270192)  2026-02-13T15:55Z [----] followers, [----] engagements


"EMA $MGX $BEAM $PRME guide dependent off target activity likely to be higher"  
[X Link](https://x.com/BiotechAnalysst/status/1967882404997239277)  2025-09-16T09:25Z [----] followers, [----] engagements


"#Astellas not buying $TSHA re but $SGMO $TSHA - Astellas + $SGMO RETT Wedbush: STAC-BBB Neuro Capsids $TSHA - Astellas + $SGMO RETT Wedbush: STAC-BBB Neuro Capsids"  
[X Link](https://x.com/BiotechAnalysst/status/1979124753119039813)  2025-10-17T09:58Z [----] followers, [----] engagements


"$QURE $CSL 94% of patients (51 of 54) remained free from the burden of continuous prophylaxis treatment through #five #years following a single infusion of #HEMGENIX demonstrating sustained therapeutic benefit mean factor IX activity levels remained strong at 36.1% #ASH25"  
[X Link](https://x.com/BiotechAnalysst/status/1997714307472339369)  2025-12-07T17:06Z [----] followers, [----] engagements


"$XBI WF [----] SMID Cap Biotech Outlook Top Picks: $ARGX $ANNX Upgrades: $GLUE PT $22 [----] Key Catalysts in Our Coverage"  
[X Link](https://x.com/BiotechAnalysst/status/2000880426114802138)  2025-12-16T10:47Z [----] followers, [----] engagements


"$SGMO case study from Sangamo to be presented in April At #ASIA conference you can see every other presenation has a #NAMED presenter but this one . who will present this in ASIA #Astellas"  
[X Link](https://x.com/BiotechAnalysst/status/2002041873645580783)  2025-12-19T15:42Z [----] followers, 18.2K engagements


"#Astellas says "We see #more platform development together with (them) Sangamo $SGMO to actually create the next generation of gene therapy $SGMO case study from Sangamo to be presented in April At #ASIA conference you can see every other presenation has a #NAMED presenter but this one . who will present this in ASIA #Astellas https://t.co/EJGfe10b9C $SGMO case study from Sangamo to be presented in April At #ASIA conference you can see every other presenation has a #NAMED presenter but this one . who will present this in ASIA #Astellas https://t.co/EJGfe10b9C"  
[X Link](https://x.com/BiotechAnalysst/status/2002047172997771615)  2025-12-19T16:03Z [----] followers, [----] engagements


"science to change tomorrow content of #Astellas presentation at #JPM26 $SGMO offers access to engineered capsid capable of bypassing the blood-brain barrier allowing for convenient IV delivery of promising AAV-based therapies for neurological diseases https://newsroom.astellas.com/JPM-2026-Pioneering-science-to-change-tomorrow https://newsroom.astellas.com/JPM-2026-Pioneering-science-to-change-tomorrow"  
[X Link](https://x.com/BiotechAnalysst/status/2004470200587243642)  2025-12-26T08:31Z [----] followers, [----] engagements


"Pretty sure now #Astellas will BUYOUT $SGMO @ #JPM26 $SGMO case study from Sangamo to be presented in April At #ASIA conference you can see every other presenation has a #NAMED presenter but this one . who will present this in ASIA #Astellas https://t.co/EJGfe10b9C $SGMO case study from Sangamo to be presented in April At #ASIA conference you can see every other presenation has a #NAMED presenter but this one . who will present this in ASIA #Astellas https://t.co/EJGfe10b9C"  
[X Link](https://x.com/BiotechAnalysst/status/2004471624368578585)  2025-12-26T08:37Z [----] followers, 11.4K engagements


"RJ January [----] Healthcare Top Picks List adding $ALHC $AXGN $TYRA $UHS"  
[X Link](https://x.com/BiotechAnalysst/status/2007159729869729834)  2026-01-02T18:39Z [----] followers, [----] engagements


"Astellas CEO . $SGMO https://www.linkedin.com/posts/naoki-okamura_jpm2026-oneastellas-changingtomorrow-activity-7413731155666972672-GsF_/utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAAJADAkBzV4TwdZc8RXlwfUmwRW2beOtoqY&utm_campaign=copy_link https://www.linkedin.com/posts/naoki-okamura_jpm2026-oneastellas-changingtomorrow-activity-7413731155666972672-GsF_/utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAAJADAkBzV4TwdZc8RXlwfUmwRW2beOtoqY&utm_campaign=copy_link"  
[X Link](https://x.com/BiotechAnalysst/status/2008078496933806529)  2026-01-05T07:29Z [----] followers, [----] engagements


"$XBI $IBB $NBI Big Biotech Inflows to Kick Off 2026"  
[X Link](https://x.com/BiotechAnalysst/status/2009511270366736849)  2026-01-09T06:23Z [----] followers, [---] engagements


"#JPM26 04:30PM $BIIB $BLCO $KOD $MDGL $UTHR 05:15PM $BAX $KNSA $ONT $REGN $TWST $VKTX $VRTX 06:00PM $CNMD $DNTH $INSM $SNDX $TMDX 06:45PM $AMGN $CPRX $GH $IDYA $NVST $TERN 07:30PM $ADPT $CRMD $DGX $ENOV $MRK $MRNA $MTD $NRIX $TVTX 08:15PM $ARCT $ASTH $BBOT $DAWN $EXEL $NVDA"  
[X Link](https://x.com/BiotechAnalysst/status/2010619708207473047)  2026-01-12T07:47Z [----] followers, [----] engagements


"Q&A: $BMY Bristol Myers CEO Chris Boerner on megamergers Trump in [----] and #brain #health as the '#next #frontier' $SGMO STAC-BBB https://endpoints.news/jpm26-qa-with-bristol-myers-squibb-ceo-chris-boerner-on-2026-outlook/ $SGMO Cantor Deep Dive: Blood-Brain Barrier Crossing Technologies" STAC-BBB 700x higher expr. vs AAV9 100x lower liver exposure vs AAV9 Cantor take $SGMO STAC-BBB appears to primarily target neurons regardless of promoter could unlock #multiple neurology #epigenetic programs https://t.co/ukCX22Mo0j"  
[X Link](https://x.com/BiotechAnalysst/status/2011464850430415139)  2026-01-14T15:46Z [----] followers, [----] engagements


"#Astellas CEO says on #gene #therapy: "we try to be innovative we want to provide transformative treatments to patients in need" "the best way to do it is to transfer the gene to patients." believe gene therapy can be future technology. re $SGMO Fabry https://www.biotechtv.com/post/astellas-pharma-january-14-2026 https://www.biotechtv.com/post/astellas-pharma-january-14-2026"  
[X Link](https://x.com/BiotechAnalysst/status/2011717545926238498)  2026-01-15T08:30Z [----] followers, [----] engagements


"#JPM26 "#Astellas has a healthy appetite for business development dealmaking for Okamura is about #new #technologies new assets that strengthen our pipeline or even better a #technology #Platform re $SGMO platforms: GT F+H GE epi+ MINT delivery https://www.fiercepharma.com/pharma/astellas-ceo-resists-rescue-bd-6b-xtandi-patent-cliff-nears https://www.fiercepharma.com/pharma/astellas-ceo-resists-rescue-bd-6b-xtandi-patent-cliff-nears"  
[X Link](https://x.com/BiotechAnalysst/status/2012104676209303699)  2026-01-16T10:08Z [----] followers, [----] engagements


"i hope #Astellas will talk about Fabry too @ Worldsymposium February [--] "Transforming Rare Diseases with #Gene #Therapies and Advanced Technologies" . $SGMO "  
[X Link](https://x.com/BiotechAnalysst/status/2012110638630457604)  2026-01-16T10:32Z [----] followers, [----] engagements


"Astellas says $SGMO partnership is very active but can not discuss publicly . says "stay tuned" on #Angelman syndrome https://www.genengnews.com/topics/genome-editing/astellas-takes-aim-at-xlmtm-again-now-with-myoaav-capsid-based-gene-therapy/ What happened to Angelman's syndrome @SangamoTx $SGMO Partnership opportunity https://t.co/aQInNwej22 https://www.genengnews.com/topics/genome-editing/astellas-takes-aim-at-xlmtm-again-now-with-myoaav-capsid-based-gene-therapy/ What happened to Angelman's syndrome @SangamoTx $SGMO Partnership opportunity https://t.co/aQInNwej22"  
[X Link](https://x.com/BiotechAnalysst/status/2013886840017756538)  2026-01-21T08:10Z [----] followers, 14.1K engagements


"Astellas Scouting for innovative gene & cell therapies Perceptive Advisors' Joe Edelman calls #gene #therapy #UNDERHYPED . says power of it is enormous . says will see some big wins in gene therapy . re $SGMO Fabry (start minute 5:58) https://t.co/vKDWuOycNK Perceptive Advisors' Joe Edelman calls #gene #therapy #UNDERHYPED . says power of it is enormous . says will see some big wins in gene therapy . re $SGMO Fabry (start minute 5:58) https://t.co/vKDWuOycNK"  
[X Link](https://x.com/BiotechAnalysst/status/2014019967050531000)  2026-01-21T16:59Z [----] followers, [----] engagements


"$SGMO "change management" in "period of change " re Astellas / Japanese / buyout / change of management"  
[X Link](https://x.com/BiotechAnalysst/status/2014357021298970948)  2026-01-22T15:18Z [----] followers, [----] engagements


"$LLY #Astellas #Roche . and sparing of milestones $1.5B"  
[X Link](https://x.com/BiotechAnalysst/status/2014368508394582064)  2026-01-22T16:04Z [----] followers, [----] engagements


"Timeline Merger Between $LLY and $VTYX Nov [--] 2023: VTYX confidentiality agreement with $SNY Jul [--] 2024: VTYX confidentiality agreement with LLY Jan [--] 2026: VTYX and LLY sign and publicly announce the merger agreement re " why does the deal take so long $SGMO ""  
[X Link](https://x.com/BiotechAnalysst/status/2014584251518210404)  2026-01-23T06:21Z [----] followers, [----] engagements


"$PGEN POINT72 Steven A Cohen adding 15.6M shares #TANG #CAPITAL NEW 12.4M shares $PGEN position #POINT72 ASSET (Steven A Cohen) NEW 2.7M its TANG + COHEN VS Shorts now https://t.co/u1puCEEZrd #TANG #CAPITAL NEW 12.4M shares $PGEN position #POINT72 ASSET (Steven A Cohen) NEW 2.7M its TANG + COHEN VS Shorts now https://t.co/u1puCEEZrd"  
[X Link](https://x.com/BiotechAnalysst/status/2014815382901588439)  2026-01-23T21:39Z [----] followers, [----] engagements


"$CRVS Seven Clarifications on SQL/ ITK in AD Against a #Short #Report We caught up with $CRVS following short report on X Here is what we will counter-detail vs. the short report: BLOCKBUSTER drug no actually in fact BLOCKBUSTER SHORT It is finally time to short $crvs The market is pricing Soquelitinib as this de risked blockbuster. In reality though and Ill go into detail below it is a commercially OBSOLETE asset with engineered/cherry picked data and BLOCKBUSTER drug no actually in fact BLOCKBUSTER SHORT It is finally time to short $crvs The market is pricing Soquelitinib as this de risked"  
[X Link](https://x.com/BiotechAnalysst/status/2016035224111509596)  2026-01-27T06:27Z [----] followers, 51.2K engagements


"Astellas @ worldsymposium "Transforming Rare Diseases with #Gene #Therapies and Advanced Technologies" . $SGMO . Astellas presents Wednesday on Gene Therapies and Advanced Technologies. 🤔 maybe $SGMO Astellas presents Wednesday on Gene Therapies and Advanced Technologies. 🤔 maybe $SGMO"  
[X Link](https://x.com/BiotechAnalysst/status/2017250093989085440)  2026-01-30T14:54Z [----] followers, [----] engagements


"so #AETNA and #BCBS are ready to pay for BOTH $SGMO gene therapies #Patients want it #payors want it #FDA wants it . this stock will go up multiples soon enough . just IMHO #yolo #once_in_a_lifetime_opportunity"  
[X Link](https://x.com/BiotechAnalysst/status/2018367358193066090)  2026-02-02T16:54Z [----] followers, [----] engagements


"$SGMO dont know but i guess cash into [----] now cash into #BLA acceptance. cash in Fabry #AA approval wait no chapter [--] but the told me noone wanted shares they told me offering would have to be in low .20s but now .47 no low ball offers for partnering anymore"  
[X Link](https://x.com/BiotechAnalysst/status/2018695053670023204)  2026-02-03T14:36Z [----] followers, [----] engagements


"didnt know it was $250M for sangamo AI articles are so smart"  
[X Link](https://x.com/BiotechAnalysst/status/2019009506181542148)  2026-02-04T11:25Z [----] followers, [----] engagements


"$SGMO This graph tells you everything you need to know about the efficacy of Isa-vec for Fabry. It is bind boggling that a big pharma hasn't scooped this up for $1billion+. Fabry has a yearly cost of over $350k per patient"  
[X Link](https://x.com/BiotechAnalysst/status/2019014725229535658)  2026-02-04T11:46Z [----] followers, [----] engagements


"$EIKN down 12% in [--] hours . welcome to biotech markets PS: noone needs biotech IPOs 🔬 @EikonTX is a late-stage clinical biopharmaceutical company dedicated to advancing breakthrough therapies through the purposeful integration of science and engineering. 🎉 Thrilled to welcome you to Nasdaq $EIKN #NasdaqListed https://t.co/TSR2ivRNLX 🔬 @EikonTX is a late-stage clinical biopharmaceutical company dedicated to advancing breakthrough therapies through the purposeful integration of science and engineering. 🎉 Thrilled to welcome you to Nasdaq $EIKN #NasdaqListed https://t.co/TSR2ivRNLX"  
[X Link](https://x.com/BiotechAnalysst/status/2019511944433266992)  2026-02-05T20:42Z [----] followers, [----] engagements


"GENIOUS MOVE from $SGMO to raise [--] days ago 👏 re #markets_in_turmoil WF $SGMO New #Cardiac Data interesting PT $2 WORLDSymposium Data for ST-920 Show Stabilized Cardiac Function in Fabry Patients await updates on partnership for ST-920 https://t.co/R7WBQipqBk WF $SGMO New #Cardiac Data interesting PT $2 WORLDSymposium Data for ST-920 Show Stabilized Cardiac Function in Fabry Patients await updates on partnership for ST-920 https://t.co/R7WBQipqBk"  
[X Link](https://x.com/BiotechAnalysst/status/2019513272718836203)  2026-02-05T20:47Z [----] followers, [----] engagements


"$SGMO there is no competition $IDEA No Significant Renal Benefit With #Lucerastat in Fabry Disease .The LSM treatment difference was not statistically significant re "oral competition" https://www.hcplive.com/view/phase-3-modify-no-significant-renal-benefit-lucerastat-in-fabry-disease $IDIA #Idorsia Clear route to registration positions lucerastat as the potential first oral therapy for all patients with Fabry disease. $SGMO $QURE https://t.co/r5mD2rlwFe https://www.hcplive.com/view/phase-3-modify-no-significant-renal-benefit-lucerastat-in-fabry-disease $IDIA #Idorsia Clear route to"  
[X Link](https://x.com/BiotechAnalysst/status/2019678605706686552)  2026-02-06T07:44Z [----] followers, [----] engagements


"fantastic article examining whether $BLUE Lyfgenia #Gene #Therapy has an advantage over $VRTX $CRSP Casgevy (Crispr) in that it requires fewer cells to be collected for gene correction. Some patients have had to come in for five different hospital stays . some give up Vertexs CRISPR treatment for sickle cell disease hits unexpected roadblock A great @Jasonmmast scoop. https://t.co/Q8FBCsbYDJ Vertexs CRISPR treatment for sickle cell disease hits unexpected roadblock A great @Jasonmmast scoop. https://t.co/Q8FBCsbYDJ"  
[X Link](https://x.com/BiotechAnalysst/status/2019689568086421765)  2026-02-06T08:28Z [----] followers, [----] engagements


"confirmation Gena Wang left Barclays and $SGMO is no longer covered by them @SP28947316 what i am hearing is that gena wang . barclays analyst is leaving . barclays still covering sgmo again . no research note from all [--] analysts for [--] months . go figure https://t.co/8sJjOeAuh5 @SP28947316 what i am hearing is that gena wang . barclays analyst is leaving . barclays still covering sgmo again . no research note from all [--] analysts for [--] months . go figure https://t.co/8sJjOeAuh5"  
[X Link](https://x.com/BiotechAnalysst/status/2019733729615417853)  2026-02-06T11:23Z [----] followers, [----] engagements


"$BEAM also deleting Barclays and Gena Wang from ther coverage page . $SLDB showing Barclays still but reased Gena Wang"  
[X Link](https://x.com/BiotechAnalysst/status/2019734774806630610)  2026-02-06T11:27Z [----] followers, [---] engagements


"$QURE Two patients at the 4x1013 gc/kg dose experienced asymptomatic Grade3 #liver enzyme #elevations confirmed as dose-limiting #toxicity following an IDMC review $QURE has #paused additional #dosing in the mid- and high-dose cohorts pending further evaluation re $SGMO FABRY"  
[X Link](https://x.com/BiotechAnalysst/status/2019745311606911313)  2026-02-06T12:09Z [----] followers, [----] engagements


"@floszcrxl $QURE Two patients at the 4x1013 gc/kg dose experienced asymptomatic Grade3 #liver enzyme #elevationsconfirmed as dose-limiting #toxicity following an IDMC review $QURE has #paused additional #dosing in the mid- and high-dose cohorts pending further evaluation re $SGMO FABRY"  
[X Link](https://x.com/BiotechAnalysst/status/2019745528502735025)  2026-02-06T12:10Z [----] followers, [----] engagements


"$QURE only 50% off ERT and Grade3 #liver enzyme #elevations confirmed as dose-limiting #toxicity 😂 compare this to 100% of $SGMO patients off ERT for over [--] years and 100% clean safety $QURE just dropped Fabry 🔥 AMT-191 shows sustained supraphysiological -Gal A activity for [--] year stable lyso-Gb3 and more than 50% () of patients off ERT. Gene therapy doing what chronic infusions never could: functional cure. ✌ Full press release: https://t.co/nY8n9uELuB https://t.co/l9MzpeSiNP $QURE just dropped Fabry 🔥 AMT-191 shows sustained supraphysiological -Gal A activity for [--] year stable lyso-Gb3"  
[X Link](https://x.com/BiotechAnalysst/status/2019747908812153265)  2026-02-06T12:20Z [----] followers, [----] engagements


"@doepke_michel $QURE Two patients at the 4x1013 gc/kg dose experienced Grade3 #liver enzyme #elevations confirmed as dose-limiting #toxicity following an IDMC review $QURE has #paused additional #dosing in the mid- and high-dose cohorts pending further evaluation"  
[X Link](https://x.com/BiotechAnalysst/status/2019748245757362313)  2026-02-06T12:21Z [----] followers, [---] engagements


"$QURE Fabry = TOXIC $QURE Two patients at the 4x1013 gc/kg dose experienced asymptomatic Grade3 #liver enzyme #elevations confirmed as dose-limiting #toxicity following an IDMC review $QURE has #paused additional #dosing in the mid- and high-dose cohorts pending further evaluation re $SGMO FABRY $QURE Two patients at the 4x1013 gc/kg dose experienced asymptomatic Grade3 #liver enzyme #elevations confirmed as dose-limiting #toxicity following an IDMC review $QURE has #paused additional #dosing in the mid- and high-dose cohorts pending further evaluation re $SGMO FABRY"  
[X Link](https://x.com/BiotechAnalysst/status/2019750174193488278)  2026-02-06T12:29Z [----] followers, [----] engagements


"$QURE thank god Both patients have responded to corticosteroid therapy and $QURE did not produce an $NTLA like Grade4 Hy's Law case $QURE only 50% off ERT and Grade3 #liver enzyme #elevations confirmed as dose-limiting #toxicity 😂 compare this to 100% of $SGMO patients off ERT for over [--] years and 100% clean safety $QURE only 50% off ERT and Grade3 #liver enzyme #elevations confirmed as dose-limiting #toxicity 😂 compare this to 100% of $SGMO patients off ERT for over [--] years and 100% clean safety"  
[X Link](https://x.com/BiotechAnalysst/status/2019753487970500774)  2026-02-06T12:42Z [----] followers, [----] engagements


"@Prof_Dollar reality is actually $QURE doing ONLY oldschool gene therapy . for $SGMO Gene Therapy was just a hedge to bridge to high tech until delivery was solved . and even with their bridge only they are best in class with 100% safety (actually in all trials they do)"  
[X Link](https://x.com/BiotechAnalysst/status/2019756899697041434)  2026-02-06T12:55Z [----] followers, [---] engagements


"@DesertDweller93 how will they bring the drug to people then with their AAV5 if patients have AAV5 antibodies "  
[X Link](https://x.com/BiotechAnalysst/status/2019759329415446942)  2026-02-06T13:05Z [----] followers, [---] engagements


"@DesertDweller93 Whats the difference beteeen aav5 and aav6 ab"  
[X Link](https://x.com/BiotechAnalysst/status/2019761978374262998)  2026-02-06T13:15Z [----] followers, [---] engagements


"no wonder FDA doesnt trust $QURE always spinning hiding esoteric data using . and then only oldschood gene therapy . just imho"  
[X Link](https://x.com/BiotechAnalysst/status/2019793123124088993)  2026-02-06T15:19Z [----] followers, [----] engagements


"@DudeBiotech $QURE 3%"  
[X Link](https://x.com/BiotechAnalysst/status/2019793210378166575)  2026-02-06T15:20Z [----] followers, [---] engagements


"Leerink $QURE Fabry "less clear safety profile" $qure AAV Fabry gene therapy does not sound as promising as $sgmo's with variability in transgene expression and dose-limiting liver enzymes. Preliminary take pending full presentation today. https://t.co/DgdciVjMNO $qure AAV Fabry gene therapy does not sound as promising as $sgmo's with variability in transgene expression and dose-limiting liver enzymes. Preliminary take pending full presentation today. https://t.co/DgdciVjMNO"  
[X Link](https://x.com/BiotechAnalysst/status/2019837566435078304)  2026-02-06T18:16Z [----] followers, [----] engagements


"$QURE William Blair says $SGMO initiated rolling BLA for gene therapy for Fabry ST-920 with expectations it will complete the submission Q2 $QURE has not yet shared eGFR data which is the surrogate endpoint being used by FDA *** path forward for $QURE AMT-130 is #uncertain***"  
[X Link](https://x.com/BiotechAnalysst/status/2019841921074463211)  2026-02-06T18:33Z [----] followers, 11.3K engagements


"$qure wheres the egfr data Why arentvthey reporting. Doing the esoteric data again. Like hd. Fda will punish them. $QURE #Fabry https://t.co/FpzAoUtsQW $QURE #Fabry https://t.co/FpzAoUtsQW"  
[X Link](https://x.com/BiotechAnalysst/status/2019860550826569886)  2026-02-06T19:47Z [----] followers, [----] engagements


""Companies that need capital over-communicate." 🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣 @BiotechAnalysst $QURE doesnt show its full hand on purpose. Silence weakness. Companies that need capital over-communicate. Fabry has strategic options and will be focused in time epilepsy is coming and Huntingtons will land with force. Preclinical work stays quiet until it matters. 🤝 @BiotechAnalysst $QURE doesnt show its full hand on purpose. Silence weakness. Companies that need capital over-communicate. Fabry has strategic options and will be focused in time epilepsy is coming and Huntingtons will land with"  
[X Link](https://x.com/BiotechAnalysst/status/2019893160143368207)  2026-02-06T21:57Z [----] followers, [----] engagements


"@anssiapina if there was some $QURE would be seeing a trend now . especialy in the 1st cohort 6x10 starting aftr week 20"  
[X Link](https://x.com/BiotechAnalysst/status/2020190549735522447)  2026-02-07T17:38Z [----] followers, [----] engagements


"@RNAiAnalyst $QURE The mid and high dose is #TOXIC also why would you start with such a high dose "  
[X Link](https://x.com/BiotechAnalysst/status/2020815613803778187)  2026-02-09T11:02Z [----] followers, [---] engagements


"*** path forward for $QURE AMT-130 is #uncertain*** $QURE William Blair says $SGMO initiated rolling BLA for gene therapy for Fabry ST-920 with expectations it will complete the submission Q2 $QURE has not yet shared eGFR data which is the surrogate endpoint being used by FDA *** path forward for $QURE AMT-130 is #uncertain*** https://t.co/rjjmorrHHb $QURE William Blair says $SGMO initiated rolling BLA for gene therapy for Fabry ST-920 with expectations it will complete the submission Q2 $QURE has not yet shared eGFR data which is the surrogate endpoint being used by FDA *** path forward for"  
[X Link](https://x.com/BiotechAnalysst/status/2020881363084148874)  2026-02-09T15:23Z [----] followers, [----] engagements


"@peter_paone low balling offeres due to sgmo financial stress . sandy did not take the low ball offer . good . they will come begging to partner after approval"  
[X Link](https://x.com/BiotechAnalysst/status/2021674844782272590)  2026-02-11T19:56Z [----] followers, [----] engagements


"timeline of $BMRN for $FOLD deal. re $SGMO Fabry $BMRN $FOLD Galafold for Fabry's pts with amenable GLA mutations (35-50% of Fabry pts) potentially 100k undiagnosed Jefferies says "the most #material near-term #competitor is $SGMO Sangamo's ST-920 which is an AAV gene tx w/ BLA under AA expected Q2'26 based on Ph.1/2 data" https://t.co/f5wYyoNitH $BMRN $FOLD Galafold for Fabry's pts with amenable GLA mutations (35-50% of Fabry pts) potentially 100k undiagnosed Jefferies says "the most #material near-term #competitor is $SGMO Sangamo's ST-920 which is an AAV gene tx w/ BLA under AA expected"  
[X Link](https://x.com/BiotechAnalysst/status/2014381806661799974)  2026-01-22T16:57Z [----] followers, [----] engagements


"$XERS $SGMO drug delivery . $HALO buys Surf Bio for $400M $HALO acquires Surf Bio for a total consideration of up to $400M $HALO acquires Surf Bio for a total consideration of up to $400M"  
[X Link](https://x.com/BiotechAnalysst/status/2016526561239822565)  2026-01-28T14:59Z [----] followers, [----] engagements


"$SNY Sanofi's troubled GCS inhibitor #fails phase [--] #Fabry trial re $SGMO Fabry GT only option to cure $SGMO CEO says ST-920 Fabry GT " I have been doing drug development for [--] years and this is the most beautiful medicine I have ever seen" "ballance of effectiveness and safety " "its a very rare thing to see so much benefit" https://t.co/XCHnI6Bswp $SGMO CEO says ST-920 Fabry GT " I have been doing drug development for [--] years and this is the most beautiful medicine I have ever seen" "ballance of effectiveness and safety " "its a very rare thing to see so much benefit""  
[X Link](https://x.com/BiotechAnalysst/status/2018322488711696450)  2026-02-02T13:55Z [----] followers, [----] engagements


"$BBIO Stock down 15% on tafamidis IP news. What's the market pricing in"  
[X Link](https://x.com/BiotechAnalysst/status/2019653455451668853)  2026-02-06T06:04Z [----] followers, [----] engagements


"1 week [--] #Fabry headlines from #worldsymposium $SNY Fabry #fails to meet expectations $IDEA no renal benefit in Fabry $QURE Fabry #stops dosing on #tox do not report eGFR #high variability path forwar #unclear. $SGMO cures Fabry and stabilizes cardiac functions"  
[X Link](https://x.com/BiotechAnalysst/status/2020105633643601938)  2026-02-07T12:01Z [----] followers, [----] engagements


"$PGEN whats the short thesis"  
[X Link](https://x.com/BiotechAnalysst/status/2021500980651778544)  2026-02-11T08:26Z [----] followers, [----] engagements


"good news finaly for $SNY Beln Garijo takes over: re $PGEN $SGMO viral Vector Gene Therapy Sanofi's Board met on February [--] [----] and decided not to renew the Director mandate of Paul Hudson. As a result Paul Hudsons last day as Chief Executive Officer will be on February [--] [----] at the end of business. Beln Garijo to become Chief Executive Officer of Sanofi. Sanofi's Board met on February [--] [----] and decided not to renew the Director mandate of Paul Hudson. As a result Paul Hudsons last day as Chief Executive Officer will be on February [--] [----] at the end of business. Beln Garijo to become"  
[X Link](https://x.com/BiotechAnalysst/status/2021861651645886964)  2026-02-12T08:19Z [----] followers, [----] engagements


"Jefferies $SGMO cont. discussions w/ partners to finalize Fabry deal pharma interest at world become more valuable as advances through regulatory process/ derisking ahead (BLA accept to review) which should put some pressure on partner convos submit [--] out of [--] modules this month"  
[X Link](https://x.com/BiotechAnalysst/status/2021957139938283977)  2026-02-12T14:38Z [----] followers, [----] engagements


"breaking .40 on $SGMO looking good Jefferies $SGMO cont. discussions w/ partners to finalize Fabry deal pharma interest at world become more valuable as advances through regulatory process/ derisking ahead (BLA accept to review) which should put some pressure on partner convos submit [--] out of [--] modules this month https://t.co/8mAKRQVgIq Jefferies $SGMO cont. discussions w/ partners to finalize Fabry deal pharma interest at world become more valuable as advances through regulatory process/ derisking ahead (BLA accept to review) which should put some pressure on partner convos submit [--] out of 4"  
[X Link](https://x.com/BiotechAnalysst/status/2022341921373569340)  2026-02-13T16:07Z [----] followers, [----] engagements


"$VYGR Resignation of Chief Medical Officer On February [--] [----] Toby Ferguson M.D. Ph.D. notified $VYGR of his decision to resign from his position as Chief Medical Officer of the Company and from any and all other positions he holds .but. neuroshuttle re $SGMO STAC-bbb $VYGR losing bigtime VS $SGMO capsids . so. $VYGR capitulated on AAV Capsids and introducing: "Voyager-NeuroShuttle Non-Viral Platform" 🤓 "Proof of concept murine data" "Preclinical studies ongoing to identify potential safety profile of ALPL-VYGR-NeuroShuttle" good luck https://t.co/g9BC4PV6dB $VYGR losing bigtime VS $SGMO"  
[X Link](https://x.com/BiotechAnalysst/status/2022374467146584406)  2026-02-13T18:17Z [----] followers, [----] engagements


"$IRON CRL Creates Some Uncertainty but We Remain Confident on Approval by '27 JEF attended exclusive analyst call after IRON received CRL for Bitopertin PT to 128"  
[X Link](https://x.com/BiotechAnalysst/status/2022608675848741105)  2026-02-14T09:47Z [----] followers, [---] engagements


"Roche will buy $sgmo now $SGMO Sangamo Therapeutics to Regain Full Rights to Hemophilia A Gene Therapy Program Following Pfizers Decision to Cease Development of Giroctocogene Fitelparvovec $SGMO Sangamo Therapeutics to Regain Full Rights to Hemophilia A Gene Therapy Program Following Pfizers Decision to Cease Development of Giroctocogene Fitelparvovec"  
[X Link](https://x.com/BiotechAnalysst/status/1873842122090336691)  2024-12-30T21:22Z [----] followers, 12.8K engagements


"noone wants #CRISPR #DIRT $CRSP Vertexs $VRTX CRISPR cure for sickle cell has been slow to launch reaching just [--] patients in [--] years. Doctors told STAT there's been a surprising culprit: They often can't collect enough cells to make the therapy https://t.co/eLOUz2QMyE Vertexs $VRTX CRISPR cure for sickle cell has been slow to launch reaching just [--] patients in [--] years. Doctors told STAT there's been a surprising culprit: They often can't collect enough cells to make the therapy https://t.co/eLOUz2QMyE"  
[X Link](https://x.com/BiotechAnalysst/status/2019419143494410406)  2026-02-05T14:33Z [----] followers, [----] engagements


"shorted $CRSP today . they even turned away from CRISPR . almost [--] billion cap . Vertexs CRISPR treatment for sickle cell disease hits unexpected roadblock A great @Jasonmmast scoop. https://t.co/Q8FBCsbYDJ Vertexs CRISPR treatment for sickle cell disease hits unexpected roadblock A great @Jasonmmast scoop. https://t.co/Q8FBCsbYDJ"  
[X Link](https://x.com/BiotechAnalysst/status/2019440809372799411)  2026-02-05T15:59Z [----] followers, [----] engagements


"@Jota5571189851 no that was cantor and wellsfargo"  
[X Link](https://x.com/BiotechAnalysst/status/2021958146391257467)  2026-02-12T14:42Z [----] followers, [---] engagements


"$XBI Jefferies HC 7AM: $AKBA 7:30AM: $BIOA 8AM: $KYTX $RAPP 8:30AM: $CABA $DNTH 9AM: $ACRS $CPRX 9:30AM: $BBOT $CYTK $KNSA $SUPN 10AM: $ALGS $DYN 10:30AM: $ANRO $JBIO $OPCH $REGN 11AM $ANAB 11:30AM: $BMEA $CDTX $KOD $TERN : $ARCT $CADL $EYPT $IMTX $PROK $RZLT $ZYME"  
[X Link](https://x.com/BiotechAnalysst/status/1990385931329691726)  2025-11-17T11:46Z [----] followers, [----] engagements


"#TANG #CAPITAL NEW 12.4M shares $PGEN position #POINT72 ASSET (Steven A Cohen) NEW 2.7M its TANG + COHEN VS Shorts now happy weekend $PGEN shorts https://t.co/9MPBTsXk8p happy weekend $PGEN shorts https://t.co/9MPBTsXk8p"  
[X Link](https://x.com/BiotechAnalysst/status/1990476929703494077)  2025-11-17T17:47Z [----] followers, [----] engagements


"#JPM26 10:30AM $ARWR $ASND $BBIO $BMY $DXCM $KRYS $SRRK 11:15 $ARGX $BHVN $CRSP $INCY $IRTC $JNJ $MAZE $TXG 12:00PM $ALNY $BRKR $CBLL $COR $NOVN $PTCT $SRPT $XENE 12:45 $ADMA $CYTK $INNV $INSP $NBIX $PFE $SASY $SMMT 01:30 $BCRX $MDT $PACB $RARE $RVMD $ZTS 02:15 $BCAX $BMRN $GILD"  
[X Link](https://x.com/BiotechAnalysst/status/2010618247205253356)  2026-01-12T07:42Z [----] followers, [----] engagements


"maybe Sandy isnt the biggest liar . but their "partners" wheres the more and next gen Astellas #Astellas says "We see #more platform development together with (them) Sangamo $SGMO to actually create the next generation of gene therapy https://t.co/naUtcuMRXh #Astellas says "We see #more platform development together with (them) Sangamo $SGMO to actually create the next generation of gene therapy https://t.co/naUtcuMRXh"  
[X Link](https://x.com/BiotechAnalysst/status/2020889607802425503)  2026-02-09T15:56Z [----] followers, [----] engagements


"$PGEN Goldman Sachs adding 1.4M shares"  
[X Link](https://x.com/BiotechAnalysst/status/2021501460018757974)  2026-02-11T08:28Z [----] followers, [----] engagements


"$SGMO Fabry valuation: $BMRN $FOLD slides from todays"  
[X Link](https://x.com/BiotechAnalysst/status/2021672283035644159)  2026-02-11T19:46Z [----] followers, [----] engagements


"$BMRN what a loser"  
[X Link](https://x.com/BiotechAnalysst/status/2021932172005797938)  2026-02-12T12:59Z [----] followers, [---] engagements


"MIZUHO $BBIO HITS BEST CASE SCENARIO"  
[X Link](https://x.com/BiotechAnalysst/status/2021949840884941158)  2026-02-12T14:09Z [----] followers, [----] engagements


"$BBIO VS $BMRN VS $ASND infigratinib vs Voxzogo & TransCon CNP monotherapy (JEF)"  
[X Link](https://x.com/BiotechAnalysst/status/2021952216685531303)  2026-02-12T14:19Z [----] followers, [----] engagements


"PIPER increasing $BBIO PT to $111/sh (previously $98/sh) due to higher peak sales estimates for infigratinib"  
[X Link](https://x.com/BiotechAnalysst/status/2021961370053513217)  2026-02-12T14:55Z [----] followers, [----] engagements


"$CRSP Casgevy continues to operate at a significant loss. Based upon $CRSP's 10-K filings we estimate total program #costs for Casgevy in [----] were $539M in [----] sales will need to exceed $600M for the franchise to break even #Crispr_Dirt #noone_wants_alien_bacteria_junk Vertexs CRISPR treatment for sickle cell disease hits unexpected roadblock A great @Jasonmmast scoop. https://t.co/Q8FBCsbYDJ Vertexs CRISPR treatment for sickle cell disease hits unexpected roadblock A great @Jasonmmast scoop. https://t.co/Q8FBCsbYDJ"  
[X Link](https://x.com/BiotechAnalysst/status/2022370139451052164)  2026-02-13T17:59Z [----] followers, [----] engagements


"$IRON Bitopertin Receives #CRL; Ongoing Confirmatory Trial May Be Able to Support Approval"  
[X Link](https://x.com/BiotechAnalysst/status/2022412840238526702)  2026-02-13T20:49Z [----] followers, [---] engagements


"CANTOR says $IRON Bitopertin CRL/Stock Weakness Represents One of the Best #Buying Opportunities We've Ever Seen. this represents a #no-#brainer buying opportunity. We have #extremely high #confidence in the Phase [--] trial reading out positively "  
[X Link](https://x.com/BiotechAnalysst/status/2022609549450961230)  2026-02-14T09:51Z [----] followers, [---] engagements


"TD COWEN: $SGMO Fabry topline Ph1/2 STAAR trial data supports a potential #accelerated #approval. data strongly trending toward stability if not potential #recovery of #kidney function. stat sig above those from Replagal Fabrazyme and Galafold #cardiac EPs stabilized"  
[X Link](https://x.com/anyuser/status/1939752645977346278)  2025-06-30T18:27Z [----] followers, [----] engagements


"top [---] monogenic diseases $SGMO can cure ranked by patient populations mutation-specific targetability existing treatment status commercial impact & likelihood of insurance reimbursement. Literally limitless potential here thanks the the science of @SangamoTx HT/@alamentarius"  
[X Link](https://x.com/anyuser/status/1949500092861305089)  2025-07-27T16:00Z [----] followers, 10.4K engagements


"Astellas reports tonight 2:30 am ET re $SGMO Mint or other partnership . @BiotechAnalysst Closing in on #MINT collab Astellas expects more platform development with $SGMO for next gen. SM ramped up his comments at Jefferies saying integrase insertion potential to be future of GT and SGMO. Talking to a number of companies (jun 4) https://t.co/TeCN5wNHjG @BiotechAnalysst Closing in on #MINT collab Astellas expects more platform development with $SGMO for next gen. SM ramped up his comments at Jefferies saying integrase insertion potential to be future of GT and SGMO. Talking to a number of"  
[X Link](https://x.com/anyuser/status/1950265449502962110)  2025-07-29T18:41Z [----] followers, [----] engagements


"$SGMO Barclays PT $5 2Q25 #cash runway #extended into 4Q25; eyes on #Fabry #collab and pipeline updates"  
[X Link](https://x.com/anyuser/status/1953835186828828857)  2025-08-08T15:06Z [----] followers, [----] engagements


"$SGMO Upcoming Events page just updated"  
[X Link](https://x.com/BiotechAnalysst/status/1960753278733705334)  2025-08-27T17:16Z [----] followers, [----] engagements


"$SGMO @ #NeuPSIG2025 neuroscience and inflammation Consultant says:"  
[X Link](https://x.com/BiotechAnalysst/status/1964594177779638641)  2025-09-07T07:38Z [----] followers, [----] engagements


"Tomorrow: $SGMO Gene Therapy on the Fast Track: CMC Perspectives on Readiness Risk and Opportunities with accelerated BLA and Launch"  
[X Link](https://x.com/BiotechAnalysst/status/1975934746577543325)  2025-10-08T14:42Z [----] followers, [----] engagements


"@meangenebio $PRME Prime Medicine Filed $200M Mixed Shelf Offering for Sale of Common Stock From Time to Time"  
[X Link](https://x.com/BiotechAnalysst/status/1986783142502383877)  2025-11-07T13:09Z [----] followers, [---] engagements


"$XBI Whats Up in Biotech Near-Term #Catalysts/ Events Ahead"  
[X Link](https://x.com/anyuser/status/1990123705066762328)  2025-11-16T18:24Z [----] followers, [----] engagements


"$QURE Management on Upcoming Type A Meeting: expects a similar group to November with #additional #leadership present"  
[X Link](https://x.com/anyuser/status/2011050624213741653)  2026-01-13T12:20Z [----] followers, [----] engagements


"HCW #raised the firm's price target on $SGMO Sangamo to $10 The firm says the accelerated clinical development plan in Fabry disease may support an application filing in the first half of 2025"  
[X Link](https://x.com/BiotechAnalysst/status/1853756773124993149)  2024-11-05T11:10Z [----] followers, [----] engagements


"$SGMO Positive mean estimated glomerular filtration rate (eGFR) slope observed in the [--] patients who had reached at least 1year follow-up indicating notable improvements in renal function QoL scores mean change in General Health score of [----] (p=0.0020) https://investor.sangamo.com/news-releases/news-release-details/sangamo-therapeutics-announces-updated-phase-12-staar-study-0 https://investor.sangamo.com/news-releases/news-release-details/sangamo-therapeutics-announces-updated-phase-12-staar-study-0"  
[X Link](https://x.com/BiotechAnalysst/status/1887489261684904146)  2025-02-06T13:11Z [----] followers, [----] engagements


"$SGMO says a single IV administration of the prion ZFR delivered via STAC-BBB resulted in potent and widespread reduction of prion expression in nonhuman primates https://www.linkedin.com/posts/sangamo-therapeutics_priondisease-genetherapy-genomicmedicine-activity-7306372435602259969-QBN7utm_source=share&utm_medium=member_android&rcm=ACoAAAn-aOYBj8ZP5ySfNCHNIjgErTQsRUJLVNg https://www.linkedin.com/posts/sangamo-therapeutics_priondisease-genetherapy-genomicmedicine-activity-7306372435602259969-QBN7utm_source=share&utm_medium=member_android&rcm=ACoAAAn-aOYBj8ZP5ySfNCHNIjgErTQsRUJLVNg"  
[X Link](https://x.com/BiotechAnalysst/status/1900635788766818311)  2025-03-14T19:50Z [----] followers, 15K engagements


"$XBI +10% monday $SGMO +50% monday [--]. Rare Disease (cited [--] and [--] patients worldwide for example) may get approval based on mechanism of action only - then track and follow patients to see if drug works. https://t.co/uv2nW3KEtE [--]. Rare Disease (cited [--] and [--] patients worldwide for example) may get approval based on mechanism of action only - then track and follow patients to see if drug works. https://t.co/uv2nW3KEtE"  
[X Link](https://x.com/BiotechAnalysst/status/1913860960156111191)  2025-04-20T07:43Z [----] followers, 10.5K engagements


"Best $SGMO summary ever seen . Base Case $6 PT . must read over the weekend https://t.co/sz3VLZvqKY https://t.co/sz3VLZvqKY"  
[X Link](https://x.com/BiotechAnalysst/status/1949110493676728491)  2025-07-26T14:12Z [----] followers, [----] engagements


"$SGMO PATENT FOR THE HOLY GRAIL OF GENE EDITING #MINT today July [--] https://ppubs.uspto.gov/api/patents/html/20250243512source=US-PGPUB&requestToken=eyJzdWIiOiJjZGUzMGExZS0zNDY3LTQ4ZDUtOGI5YS1kNjQxNjJmZGNjNzMiLCJ2ZXIiOiI4OGU3YzVlNC1lMmUyLTRjNzUtOTBhMi1kYzdjOTIyYjk1MjgiLCJleHAiOjB9 @Jasonmmast please check $SGMO #MINT David Liu calls it the HOLY GRAIL of gene editing https://t.co/NDdG1alymS"  
[X Link](https://x.com/BiotechAnalysst/status/1950876740743520269)  2025-07-31T11:10Z [----] followers, [----] engagements


"HCW $SGMO PT $10 Consistent execution and clear regulatory alignment support filing under the FDAs #Accelerated #approvalworkflow NAV1.7 epigenetic editing ZF Sangamo's #next-generation #genome #editing platform #MINT in contrast to RNA DNA repl. no limit to the size"  
[X Link](https://x.com/BiotechAnalysst/status/1987926661602406725)  2025-11-10T16:53Z [----] followers, 37.7K engagements


"Jefferies $SGMO Upside Scenario Price Target $25.00 +3084%"  
[X Link](https://x.com/BiotechAnalysst/status/1768527667689668899)  2024-03-15T06:40Z [----] followers, 18.9K engagements


"Jefferies $SGMO upside scenario PT $25 when: Fabry (high chance) Hemo A (high chance) TX200 CNS best in class (high chance)"  
[X Link](https://x.com/BiotechAnalysst/status/1791133633140441143)  2024-05-16T15:48Z [----] followers, 13.3K engagements


"Canaccord says importantly $SGMO $PFE demonstrated superior % mean total ABR treatment reduction (98% vs. 81% $BMRN ). as well as beating $RHHBY Hemlibra (once weekly infusion ) 87% WOW"  
[X Link](https://x.com/BiotechAnalysst/status/1816525780353974547)  2024-07-25T17:27Z [----] followers, 26.1K engagements


"Jefferies says $SGMO mgmt is confident that BD #deals are on-track; though they cannot guide to when deals will close mgmt iterated they are making progress $SGMO said they will show longer-term #Fabry followup (pivotal ph.IIb ready w/ reg alignment) in their 2Q earnings update"  
[X Link](https://x.com/BiotechAnalysst/status/1816714224938160530)  2024-07-26T05:56Z [----] followers, 16.9K engagements


"$PFE says Deliver Next Wave of Pipeline Innovation with $SGMO Hemophilia A GTx "  
[X Link](https://x.com/BiotechAnalysst/status/1818264773542174744)  2024-07-30T12:37Z [----] followers, [----] engagements


"TRUIST sees $SGMO profitable in [----]. Roche deal could be the first of #many for capsid delivery platform and epigenetic regulation multiple programs to monetize "DD on $BIIB potential for SGMO to leverage their platform to fine tune tau that builds up over time in Alzheimer's""  
[X Link](https://x.com/BiotechAnalysst/status/1821150824183058502)  2024-08-07T11:46Z [----] followers, [----] engagements


"Goldman Sachs building $SGMO position adding 700K shares more than doubling their stake"  
[X Link](https://x.com/BiotechAnalysst/status/1823668078263075028)  2024-08-14T10:28Z [----] followers, [----] engagements


"$PFE hiring for $SGMO Hemophilia A Gene Therapy "focus on #upcoming #launch for Hemophilia A""  
[X Link](https://x.com/BiotechAnalysst/status/1826287777069322511)  2024-08-21T15:58Z [----] followers, [----] engagements


"$SGMO HCW PT $5 #Holy #Grail of Gene Editing near term catalysts"  
[X Link](https://x.com/BiotechAnalysst/status/1826640930910470187)  2024-08-22T15:21Z [----] followers, [----] engagements


"Roche highlighting $ALNY and $SGMO on Slide "Key Deals" Zinc Finger molecules in Alzheimers"  
[X Link](https://x.com/BiotechAnalysst/status/1840658142423666798)  2024-09-30T07:41Z [----] followers, 10K engagements


"$XBI RBC says: "Biotech: If Historical Patterns Hold Should See A Near-Term Uptick in M&A Helping Spark the Sector""  
[X Link](https://x.com/BiotechAnalysst/status/1846215420430160132)  2024-10-15T15:43Z [----] followers, 10.8K engagements


"WOW WOW WOW $SGMO #eGFR slope #data at [--] year across all Phase 1/2 patients can serve as primary basis for #approval under Accelerated Approval pathway"  
[X Link](https://x.com/BiotechAnalysst/status/1848698685917417920)  2024-10-22T12:11Z [----] followers, 11.6K engagements


"TD Cowen: $SGMO update radically improves likely ROI for any deal. Click here for the full company update from our latest quarterly report. @bluematrix.com&source=shortyarse https://tdcowen.bluematrix.com/sellside/EmailDocViewerencrypt=2482eac4-352b-4237-bb39-a41a900e6d0d&mime=pdf&co=tdcowen&id=_SGMO_100_Bagger_ https://tdcowen.bluematrix.com/sellside/EmailDocViewerencrypt=2482eac4-352b-4237-bb39-a41a900e6d0d&mime=pdf&co=tdcowen&id=_SGMO_100_Bagger_"  
[X Link](https://x.com/BiotechAnalysst/status/1849131284334821585)  2024-10-23T16:50Z [----] followers, [----] engagements


"$SGMO marketcap hit $2.5 B in december [----] without $PFE Phase3 Hemophilia Data without #Fabry Fda #AA path without STAC-BBB without Mint gene editing without + + + + todays $SGMO marketcap is only . $312M there is NO that undervalued stock out there"  
[X Link](https://x.com/BiotechAnalysst/status/1850210420872867959)  2024-10-26T16:18Z [----] followers, 18.2K engagements


"$SGMO next Fabry update likely announcement of a global BD deal anticipates favorable upfront+near-term milestones Pts on ERT are frustrated w/ biwkly IV +symptom rebound after 10d w/ 4-5d of symptoms before next infusion Pts may switch b/w ERT or #Galafold still have symptoms"  
[X Link](https://x.com/BiotechAnalysst/status/1851308047538286693)  2024-10-29T17:00Z [----] followers, [----] engagements


"$SGMO I expect a Fabry deal on Monday with a follow up STAC-BBB deal on Tuesday"  
[X Link](https://x.com/BiotechAnalysst/status/1854896665070588302)  2024-11-08T14:40Z [----] followers, [----] engagements


"$SGMO friendly reminder #YOLO #once_in_a_lifetime_opportunity"  
[X Link](https://x.com/BiotechAnalysst/status/1854951998119886890)  2024-11-08T18:19Z [----] followers, [----] engagements


"Barlays $SGMO intention to outlicense #Fabry with ongoing late-stage discussion with potential partners. #Deal likely could be #announced in near term. We continued to see high prob of positive data and approval. Reiterate OW and increase PT to $9 to reflect Fabry program update"  
[X Link](https://x.com/BiotechAnalysst/status/1856941400408953100)  2024-11-14T06:05Z [----] followers, [----] engagements


"London Fund MARSHALL WACE buying [-------] shares of $SGMO"  
[X Link](https://x.com/BiotechAnalysst/status/1857157045578768769)  2024-11-14T20:21Z [----] followers, [----] engagements


"$SGMO Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy a Type of Chronic Neuropathic Pain #opiumcrisis NAV1.7 engineered zinc finger repressor #ZFR to specifically target the human gene SCN9A $SGMO thrilled to submit our first #neurology #IND application this quarter for ST-503 for the treatment of intractable pain due to idiopathic small fiber neuropathy and expect to be in the clinic in mid-2025 #PAIN NAV1.7 https://t.co/SffcLxUOyx $SGMO thrilled to submit our first #neurology #IND application this quarter"  
[X Link](https://x.com/BiotechAnalysst/status/1858991297278996607)  2024-11-19T21:50Z [----] followers, [----] engagements


"This is great timing and another potential source of cash due to partnering NAV1.7 ST-503 #PAIN $SGMO CEO in London speaking to pot. BP partners right now. we could see $VRTX interest as they show NAV1.7 as next wave in presentation also $PFE had interest in NAV1.7 in the past $SGMO Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy a Type of Chronic Neuropathic Pain #opiumcrisis NAV1.7 engineered zinc finger repressor #ZFR to specifically target the human gene SCN9A $SGMO Sangamo Therapeutics Announces U.S."  
[X Link](https://x.com/BiotechAnalysst/status/1859139637349933141)  2024-11-20T07:40Z [----] followers, 19.8K engagements


"$PFE Pfizer France "Would you like to be put in contact with a representative of the Pfizer medical teams . select the #product ( $SGMO #giroctocogene #fitelparvovec) concerned by your request then complete the form and validate We will contact you as soon as possible"  
[X Link](https://x.com/BiotechAnalysst/status/1863873991447920939)  2024-12-03T09:12Z [----] followers, 11.7K engagements


"looks like #EMA is expecting $SGMO $PFE Giroctocogene fitelparvovec Submission date February [----] with Accelerated assessment via this december 3rd update: "Manufacturer #expects #filing in the #fourth #quarter of 2024" https://www.horizonscangeneesmiddelen.nl/geneesmiddelen/giroctocogene-fitelparvovec-cardiovasculaire-aandoeningen-overige_niet-oncologische_hematologische_medicatie/versie2 https://www.horizonscangeneesmiddelen.nl/geneesmiddelen/giroctocogene-fitelparvovec-cardiovasculaire-aandoeningen-overige_niet-oncologische_hematologische_medicatie/versie2"  
[X Link](https://x.com/BiotechAnalysst/status/1864329883859509310)  2024-12-04T15:24Z [----] followers, 15K engagements


"so this week $PFE hires for Hemophilia gene therapies in #JAPAN in #France health professionals can contact Pfizer about $SGMO GirFit #EMA expects that Pfizer will file $SGMO GT in Q4 (within next [--] days or so) and $PFE Presenting on Sunday and MONDAY on the stage @ #ASH24"  
[X Link](https://x.com/BiotechAnalysst/status/1864350041961341314)  2024-12-04T16:44Z [----] followers, 13.9K engagements


"#ASH24 #ASH2024 $SGMO $PFE demonstrated #superior % mean total ABR treatment reduction (98% vs. 81% $BMRN ). as well as beating $RHHBY Hemlibra (once weekly infusion ) 87%"  
[X Link](https://x.com/BiotechAnalysst/status/1866112655359881513)  2024-12-09T13:28Z [----] followers, [----] engagements


"$SGMO Were excited for @pfizer #ASH2024 oral presentation today showcasing data from Ph.3 AFFINE trial of giroctocogene fitelparvovec a gene therapy that we co-developed with and licensed to PFE for the treatment of adults w/moderately severe to severe Hem A. https://t.co/Zj9sdsDcg7 Were excited for @pfizer #ASH2024 oral presentation today showcasing data from Ph.3 AFFINE trial of giroctocogene fitelparvovec a gene therapy that we co-developed with and licensed to PFE for the treatment of adults w/moderately severe to severe Hem A. https://t.co/Zj9sdsDcg7"  
[X Link](https://x.com/BiotechAnalysst/status/1866210383502971341)  2024-12-09T19:56Z [----] followers, [----] engagements


"COWEN $SGMO Positive Topline SGMO/PFE's Ph3 AFFINE Data At #ASH24 To Support Robust 7-Fig Milestone To SGMO"  
[X Link](https://x.com/BiotechAnalysst/status/1867608947516997879)  2024-12-13T16:34Z [----] followers, [----] engagements


"Hemophilia A: Bleeds Plummet After $SGMO $PFE Experimental Gene Therapy pave the way for Pfizer product to become second FDA-#approved gene therapy for hemophilia A theres every reason to believe that they will have yet another option for their patients https://www.medscape.com/viewarticle/hemophilia-bleeds-plummet-after-experimental-gene-therapy-2024a1000oysform=login&errorCode=invalidCombination®=1 https://www.medscape.com/viewarticle/hemophilia-bleeds-plummet-after-experimental-gene-therapy-2024a1000oysform=login&errorCode=invalidCombination®=1"  
[X Link](https://x.com/BiotechAnalysst/status/1871194131508437174)  2024-12-23T14:00Z [----] followers, 14.2K engagements


"Cantor highlights $SGMO How to Win in Gene Editing and Cell Therapy: the combination of non-dilutive capital and accelerated approval timelines have sent SGMO shares up +384% this year these series of fortunate events would be hard for any company to replicate ONLY $SGMO 2025"  
[X Link](https://x.com/BiotechAnalysst/status/1873771410625368142)  2024-12-30T16:41Z [----] followers, [----] engagements


"$SGMO should be down maybe $70-$100M in marketcap (25%) not ripped into half. Theres nothing wrong with the drug the data or the BLA redyness . though we wont get the $70M $PFE milestone $SGMO got a seconds from BLA drug into their pipeline. TD Cowen on that $70M"  
[X Link](https://x.com/BiotechAnalysst/status/1874080583212777606)  2024-12-31T13:10Z [----] followers, [----] engagements


"JEFF $SGMO Fabry gene tx program is now the largest value driver SGMO has alignment w/ FDA to file for #accel #approval using 52-wk eGFR data that increases appeal for pot'l partners (co is in discussions w/ #several parties and hopes to #solve 1Q25 ) https://javatar.bluematrix.com/docs/html/9c13f354-96e3-4872-9c98-1371eee0d87d.html https://javatar.bluematrix.com/docs/html/9c13f354-96e3-4872-9c98-1371eee0d87d.html"  
[X Link](https://x.com/BiotechAnalysst/status/1874875581785063714)  2025-01-02T17:49Z [----] followers, 12.9K engagements


"HCW $SGMO Selloff overdone PT $10"  
[X Link](https://x.com/BiotechAnalysst/status/1874905613425402004)  2025-01-02T19:48Z [----] followers, [----] engagements


"$SGMO says expects deal in Q1 per Jefferies: could come early Feb. $SGMO February [--] #Peter #Marks Keynote Address: "Advancing the Frontier of Gene Therapy" #Isaralgagene #civaparvovec gene therapy in adults w Fabry disease: Updated results from an ongoing phase 1/2 study (STAAR) JEFF $SGMO Fabry gene tx program is now the largest value driver SGMO has alignment w/ FDA to file for #accel #approval using 52-wk eGFR data that increases appeal for pot'l partners (co is in discussions w/ #several parties and hopes to #solve 1Q25 ) https://t.co/zs1xmK6TAe JEFF $SGMO Fabry gene tx program is now the"  
[X Link](https://x.com/BiotechAnalysst/status/1875180805695381962)  2025-01-03T14:01Z [----] followers, [----] engagements


"expecting $SGMO Fabry news from #EMA any day now"  
[X Link](https://x.com/BiotechAnalysst/status/1876282809150853354)  2025-01-06T15:00Z [----] followers, [----] engagements


"On Monday January 13th at 8am HCW will be hosting hospitality event in San Francisco: Sandy Macrae #CEO and Prathyusha Duraibabu #CFO of $SGMO will take the stage to discuss their developments and the future of gene therapy. (more info / RSVP corporateaccess@hcwco.com)"  
[X Link](https://x.com/BiotechAnalysst/status/1876288404855673144)  2025-01-06T15:23Z [----] followers, [----] engagements


"Barclays: $SGMO says inbound interest for #HemoA GT program and would transfer the program from $PFE to new partner Hemo GT #UPDATE here likely #April #Fabry deal announcement likely in Q1 #competitive #bidding upfront payment $250M milestones and double digit royalties"  
[X Link](https://x.com/BiotechAnalysst/status/1879775300424548686)  2025-01-16T06:18Z [----] followers, 16.4K engagements


"#Astellas says "We see #more platform #development together with (them) Sangamo $SGMO to actually create the next generation of gene therapy .#neuromuscular disease strategy. https://medcitynews.com/2025/01/astellas-pharma-taniguci-cancer-gene-therapy-jpm-alpmy/ https://medcitynews.com/2025/01/astellas-pharma-taniguci-cancer-gene-therapy-jpm-alpmy/"  
[X Link](https://x.com/BiotechAnalysst/status/1882739744318410763)  2025-01-24T10:38Z [----] followers, 11.8K engagements


"Cantor says $SGMO Fabry program generated buzz at the conference data update interesting with strong enzyme activity and effects on plasma biomarkers even after 18/18 patients stopped ERT. Renal function remained stable while improvements were noted in QoL and GI symptoms"  
[X Link](https://x.com/BiotechAnalysst/status/1887750239949291926)  2025-02-07T06:28Z [----] followers, [----] engagements


"Blackrock buying back 1.5M $SGMO shares as per filing today"  
[X Link](https://x.com/BiotechAnalysst/status/1887976783485575404)  2025-02-07T21:28Z [----] followers, [----] engagements


"#Goldman #Sachs buying 1.5M $SGMO shares. its actually new position as they owned 65K shares only before"  
[X Link](https://x.com/BiotechAnalysst/status/1889631043616977283)  2025-02-12T11:02Z [----] followers, [----] engagements


"$SGMO State Street buying 4.3M shares"  
[X Link](https://x.com/BiotechAnalysst/status/1890423691143528885)  2025-02-14T15:31Z [----] followers, [----] engagements


"Bernsten $XBI M&A - Who might buy whom largest demand: $MRK $PFE $BMY $ABBV and $BIIB targets: $TGTX $INSM $AXSM $ADMA $EXLS $ASND $SWTX $BBIO $KRYS $BPMC $RVMD $SMMT $SRRK $QURE $RYTM $AKRO $MRUS $EWTX $REPL $COGT"  
[X Link](https://x.com/BiotechAnalysst/status/1899379866010563054)  2025-03-11T08:40Z [----] followers, 22.4K engagements


"$SGMO HCW PT $10 $LLY Licensing deals to support key near-term #catalysts substantial upside to current valuation and believe the stock remains #undervalued relative to its advancing pipeline With the full Phase3 dataset in hand Sangamo is now evaluating next steps for SB-525"  
[X Link](https://x.com/BiotechAnalysst/status/1909280766913052719)  2025-04-07T16:23Z [----] followers, [----] engagements


"$SRPT $SGMO $QURE Gene Therapy Developers Can Breathe A Little After SRPT's FDA Regulatory Update FDA #CBER (at the division level) is open towards the #accelerated #pathway for #gene #therapy in rare diseases"  
[X Link](https://x.com/BiotechAnalysst/status/1912181061582229746)  2025-04-15T16:27Z [----] followers, [----] engagements


"$XBI STIFEL Washington DC Chatter on FDA Trump [---] more of a right to try attitude. If there is a drug that could really work for a difficult cancer rare disease FDA could work to get the file approved quickly sponsors are asked . WHY NOT FILE $SGMO $QURE $RGNX $SRPT"  
[X Link](https://x.com/BiotechAnalysst/status/1914616295074525691)  2025-04-22T09:44Z [----] followers, 12.2K engagements


"2025 CELL AND GENE THERAPY CLINICAL PIPELINE $SGMO $PGEN $QURE $RCKT $ABEO $RARE $RGNX"  
[X Link](https://x.com/BiotechAnalysst/status/1916426091662578092)  2025-04-27T09:36Z [----] followers, [----] engagements


"#Point72 (Steven A Cohen) bought 750k $SGMO calls"  
[X Link](https://x.com/BiotechAnalysst/status/1947578559603573141)  2025-07-22T08:44Z [----] followers, 10.9K engagements


"$SGMO Fabry trial patient reports: receiving ERT every other week Burian was dosed with gene therapy at Emory University H. in Atlanta Burian is doing well +hoping for FDA approval of the therapy so his daughter will have a better happier healthier future https://www.pharmalive.com/for-our-childrens-sake-the-critical-mission-of-enabling-more-flexible-clinical-trial-designs-for-cell-and-gene-therapies/ https://www.pharmalive.com/for-our-childrens-sake-the-critical-mission-of-enabling-more-flexible-clinical-trial-designs-for-cell-and-gene-therapies/"  
[X Link](https://x.com/BiotechAnalysst/status/1951196927082537299)  2025-08-01T08:22Z [----] followers, [----] engagements


"CANTOR $PGEN WOW Papzimeos Receives FDA Approval This is reassuring for $XBI biotech sector FDAs news release includes comments from Vinay Prasad We believe investors should find Dr. #Prasad's comments #reassuring in the wake of recent concerns $SGMO Fabry Partner + #AA"  
[X Link](https://x.com/BiotechAnalysst/status/1956311301073850509)  2025-08-15T11:05Z [----] followers, 15.8K engagements


"Japan #ICIEM25 program released this morning $SGMO Fabry update will be presented under #Late-#Breaking (Astellas is there too)"  
[X Link](https://x.com/BiotechAnalysst/status/1960340536537022877)  2025-08-26T13:56Z [----] followers, [----] engagements


"WE F*CKED $XERS SHORTS WE F*CKED $PGEN SHORTS WE WILL F*CK $SGMO SHORTS NEXT AND IT WILL BE THE GREATES SHORTF*CK EVER WITNESSED"  
[X Link](https://x.com/BiotechAnalysst/status/1963970991563870281)  2025-09-05T14:22Z [----] followers, [----] engagements


"BREAKING: $SGMO Updated Ph3 data on gene therapy for haemophilia A withgiroctocogene fitelparvovec "#Durability data is #impressive: sustained efficacy approaches [--] years of follow-up demonstrating the #transformative #potential of this AAV6 approach" says Wolfgang Miesbach"  
[X Link](https://x.com/BiotechAnalysst/status/1967478465181134903)  2025-09-15T06:39Z [----] followers, [----] engagements


"Aetna Gene Therapy Product Proposal $SGMO Giroctocogene fitelparvovec Hemophilia A ST920/ isaralgagene civaparvovec Fabry Disease"  
[X Link](https://x.com/BiotechAnalysst/status/1967900943082721536)  2025-09-16T10:38Z [----] followers, 10.8K engagements


"WF raising $QURE PT to $65 AMT-130 Delivers Best-Case Scenario for 3-Year Data; Compelling Setup into BLA Filing and Approval in [----] Today we are very pleased to announce alignment with the U.S. FDA on an Accelerated Approval pathway for our ST-920 gene therapy product candidate for the treatment of Fabry accelerating estimated time to potential approval by approx. [--] yrs. Learn more: https://t.co/yNgaQRLU27 https://t.co/g3u1O7pCRL Today we are very pleased to announce alignment with the U.S. FDA on an Accelerated Approval pathway for our ST-920 gene therapy product candidate for the"  
[X Link](https://x.com/BiotechAnalysst/status/1970887827010498696)  2025-09-24T16:27Z [----] followers, 18.9K engagements


"BREAKING $SGMO Pain trial just #started recruiting (means they #got the #funding to go on) now we wait for the big PR . https://clinicaltrials.gov/study/NCT06980948term=sangamo&rank=9 $SGMO Pain study - changed to recruiting today https://t.co/7ZNByukdgb https://clinicaltrials.gov/study/NCT06980948term=sangamo&rank=9 $SGMO Pain study - changed to recruiting today https://t.co/7ZNByukdgb"  
[X Link](https://x.com/BiotechAnalysst/status/1978133058193678372)  2025-10-14T16:17Z [----] followers, 17.8K engagements


"BOOOM: HUGE $SGMO Pain trial update: Its now a #Phase2 Data not [--] but [--] weeks https://www.clinicaltrials.gov/study/NCT06980948term=sangamo&rank=9&tab=history&a=5&b=6#version-content-panel https://www.clinicaltrials.gov/study/NCT06980948term=sangamo&rank=9&tab=history&a=5&b=6#version-content-panel"  
[X Link](https://x.com/BiotechAnalysst/status/1983163127714984020)  2025-10-28T13:25Z [----] followers, 61.6K engagements


"$XBI BREAKING: $SGMO A top US regulator plans to unveil a faster approach to approving custom #gene-#editing treatments a move designed to unleash a wave of industry investment that will yield cures for patients with rare diseases. https://www.bloomberg.com/news/articles/2025-10-31/fda-clears-way-for-faster-personalized-gene-editing-treatmentstaid=6904c36303359f0001c51eb2&utm_campaign=trueanthem&utm_content=business&utm_medium=social&utm_source=twitter"  
[X Link](https://x.com/BiotechAnalysst/status/1984262470819860727)  2025-10-31T14:13Z [----] followers, 11.8K engagements


"RBC $SGMO upside scenario PT $11 another meeting with the FDA in Oct. [----] notes the #FDA #reiterated its October [----] agreement for #accelerated #approval SGMO also saw stable #cardiac function no requirement for preconditioning Partnering BD discussions are ongoing"  
[X Link](https://x.com/BiotechAnalysst/status/1986683357821055398)  2025-11-07T06:33Z [----] followers, [----] engagements


"RENAISSANCE TECHNOLOGIES adding 3.3M $SGMO shares $SGMO GSA Capital adding 1.4M shares Vanguard adding 2.2M shares 🤑 https://t.co/pwCY2AS0Dh $SGMO GSA Capital adding 1.4M shares Vanguard adding 2.2M shares 🤑 https://t.co/pwCY2AS0Dh"  
[X Link](https://x.com/BiotechAnalysst/status/1989066532509610211)  2025-11-13T20:23Z [----] followers, [----] engagements


"Goldman Sachs analyst Salveen Richter moved its rating on Taysha Gene Therapies $TSHA to Buy with an $11 price target from Early-Stage #Astellas not buying $TSHA re but $SGMO https://t.co/qCG7jhxD0l #Astellas not buying $TSHA re but $SGMO https://t.co/qCG7jhxD0l"  
[X Link](https://x.com/BiotechAnalysst/status/1996581816807891145)  2025-12-04T14:06Z [----] followers, [----] engagements


"@snicobio $VYGR not the best capsid . but CAPSIDA for sure the worst https://x.com/BiotechAnalysst/status/1999790272377651217 fast comparison of 700x + 100x $SGMO vs others: $VYGR 45X lower liver transd. transd. 20- to 400-fold higher efficiency than AAV9 #Capsida Kills first dosed patient = OUT #JCR JUST-AAV up to [---] vs AAV9) liver exposure to 0.3% of AAV9 levels #affinia 50% vs 5% AAV9. https://x.com/BiotechAnalysst/status/1999790272377651217 fast comparison of 700x + 100x $SGMO vs others: $VYGR 45X lower liver transd. transd. 20- to 400-fold higher efficiency than AAV9 #Capsida Kills"  
[X Link](https://x.com/BiotechAnalysst/status/2011342287914352712)  2026-01-14T07:39Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing